Live Chat Software

Whitepapers

Single Use Optics on Ophthalmology

Single Use Optics on Ophthalmology

This paper addresses the functional and cost advantages of single use ophthalmic lens for both clinic and surgical functions. These lenses are the first in the category to provide a solution to Joint Commission infection control standards while decreasing the need for reusable medical equipment. The paper provides a cost-benefit analysis based on the VA hospital model. Discussion over the benefits of single use optics as well as the risks associated with reusable lenses is included.

Suicide Risk Assessment Case Study: Billings Clinic

Suicide Risk Assessment Case Study: Billings Clinic

In 2016, Montana’s largest healthcare organization, the Billings Clinic, conducted a trial using Voi Detect in its Emergency Department (ED) to identify individuals with suicidal ideation.

The trial objectives were as follows:

  • Implement a universal suicide risk screening practice
  • Improve the suicide risk assessment process
  • Reduce the financial cost of an effective risk assessment
  • Reduce the training requirements needed to an effective suicide risk assessment
  • Reduce the time needed to administer an effective suicide risk assessment
  • Improve workflow for both identifying patients with near-term suicide risk and determining their treatment risk assessment

Whitepaper courtesy of Voi. 

Rauland Responder 5: The VA's Nurse Call Solution

Rauland Responder 5: The VA's Nurse Call Solution

As a proud GSA partner, Rauland believes in helping the VA to provide the best care possible for veterans. More than 100 VA hospitals rely on Rauland for their nurse call communications. Download this whitepaper to learn about how Rauland is helping the VA measure, evaluate, and benchmark quality and efficiency at medical centers nationwide.
Breakthrough in IV Safety

Breakthrough in IV Safety

IV catheter placement remains the most common invasive hospital procedure performed worldwide. This whitepaper summarizes the clinical research that established the operational capabilities of the ivWatch device, and formed the basis of the data submitted to the FDA in support of the ivWatch 510(k) Premarket Notification.